Direxion Daily S&P Biotech Bear 3X Shares (LABD)
| 14.07 Delayed Data As of Jan 24 |  +1.09 / +8.40%Today’s Change | 11.09 Today|||52-Week Range 29.80 | +13.93% Year-to-Date |
Investment Objective
The investment seeks daily investment results, before fees and expenses, of 300% of the inverse of the daily performance of the S&P Biotechnology Select Industry Index. The fund, under normal circumstances, invests in swap agreements, futures contracts, short positions or other financial instruments that, in combination, provide inverse (opposite) or short leveraged exposure to the index equal to at least 80% of the fund's net assets (plus borrowing for investment purposes). The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards ("GICS"). The fund is non-diversified.
Latest LABD News
No recent news for Direxion Daily S&P Biotech Bear 3X Shares.
Performance
| 1 month | +26.49% | 3 years | -54.79% | |
| 3 months | -34.81% | 5 years | -- | |
| 1 year | -50.13% | Since inception | -51.09% |
Data through 01/25/2020
Quote Details
| Previous close | $12.98 |
| Open day’s range | 12.78 – 14.32 |
| Net asset value (NAV) | 14.05 (01/24/2020) |
| Daily volume | 6,317,954 |
| Average volume (3 months) | 2,971,780 |
Data as of 8:00pm ET, 01/24/2020
Peer Comparisonvs. Trading--inverse equity ETFs
| LABD | Category | |
|---|---|---|
| Performance 5-yr return | -- | -29.79% |
| Expense Gross exp ratio | 1.13% | 2.05% |
| Risk 5 year sharpe ratio | -- | -- |
| Net assets | $171.5M | $8.5M |
| Average market cap | -- | -- |
| Average P/E | -- | -- |
| Dividend / Share | -- | 0.15% |
Competitors
Holdings
Top 5 SectorsPortfolio weighting
| Business service | -- |
| Consumer goods | -- |
| Consumer service | -- |
| Energy | -- |
| Financial service | -- |
Top 10 HoldingsPortfolio weighting
| Holdings not available. |
